News & Events about 10x Genomics Inc.
Shares of 10x Genomics, Inc. (NASDAQ:TXG Get Rating) have earned a consensus recommendation of Hold from the eleven analysts that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and four ...
Ticker Report
3 months ago
Brinker Capital Investments LLC bought a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG Get Rating) during the second quarter, according to the company in its most recent disclosure with the Securities Exchange Commission. The fund bought 9,262 shares of the companys ...
TheStreet.com - Investing
3 months ago
Twist Bioscience, 10x Genomics, and others with large international exposure could be squeezed by global currency selloffs.Twist Bioscience, 10x Genomics, and others with large international exposure could be squeezed by global currency selloffs.Biotech investors have no shortage of troubles at the ...
Ticker Report
6 months ago
10x Genomics (NASDAQ:TXG Get Rating) had its price objective dropped by research analysts at Cowen from $90.00 to $50.00 in a report issued on Friday, The Fly reports. Cowens target price indicates a potential upside of 39.28% from the stocks current price. TXG has been the ...
10x Genomics (NASDAQ:TXG Get Rating) had its target price decreased by The Goldman Sachs Group from $80.00 to $60.00 in a report published on Thursday morning, MarketBeat.com reports. The Goldman Sachs Group currently has a neutral rating on the stock. Separately, Citigroup dropped their price ...